4.88BMarket Cap
23.82P/E TTM
Key Figures
39.960Open
40.305High
1.35MVolume
23.82P/E TTM
9.89P/E Dynamic
--Dividend TTM
1.11%Turnover Ratio
40.220Prev. Close
38.630Low
40.91MTurnover
2440.61P/E Static
-33.90P/B
0.00%Div Yield TTM
16.69%ROA
41.00052wk High
0.94Volume Ratio
2.00MNet Profit
122.00MShares
1.6800EPS TTM
1.18Beta
-307.32%ROE
12.04052wk Low
4.16%Amplitude
87.38%Gross Margin
4.88BMarket Cap
0.29Reward/Risk
1.95%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Indivior PLC's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 46 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 49.17.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Indivior PLC Highlights
StrengthsRisks
Indivior PLC News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Indivior PLC Info
Indivior PLC is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The Company provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The Company sells its products in the United States and in other selected areas of the world.
Ticker SymbolINDV
CompanyIndivior PLC
CEOCiaffoni (Joseph J)
Websitehttps://www.indivior.com/en
Shareholders
FAQs
What is the current price of Indivior PLC (INDV)?
The current price of Indivior PLC (INDV) is 40.01.
What is the symbol of Indivior PLC?
The ticker symbol of Indivior PLC is INDV.
What is the 52-week high of Indivior PLC?
The 52-week high of Indivior PLC is 41.00.
What is the 52-week low of Indivior PLC?
The 52-week low of Indivior PLC is 12.04.
What is the market capitalization of Indivior PLC?
The market capitalization of Indivior PLC is 4.88B.
Is Indivior PLC (INDV) currently rated as Buy, Hold, or Sell?
According to analysts, Indivior PLC (INDV) has an overall rating of Buy, with a price target of 49.17.
What is the Earnings Per Share (EPS TTM) of Indivior PLC (INDV)?
The Earnings Per Share (EPS TTM) of Indivior PLC (INDV) is 1.68.
